Home
>
National Drug Code (NDC)
>
HyperRHO S/D Full Dose
HyperRHO S/D Full Dose - 13533-631-02 - (Rho(D) Immune Globulin (Human))
Drug Information of HyperRHO S/D Full Dose
| Product NDC: | 13533-631 |
| Proprietary Name: | HyperRHO S/D Full Dose |
| Non Proprietary Name: | Rho(D) Immune Globulin (Human) |
| Active Ingredient(s): | 1500 [iU]/[iU] & nbsp; Rho(D) Immune Globulin (Human) |
| Administration Route(s): | INTRAMUSCULAR |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of HyperRHO S/D Full Dose
| Product NDC: | 13533-631 |
| Labeler Name: | Grifols Therapeutics Inc. |
| Product Type: | PLASMA DERIVATIVE |
| FDA Application Number: | BLA101141 |
| Marketing Category: | BLA |
| Start Marketing Date: | 19960814 |
Package Information of HyperRHO S/D Full Dose
| Package NDC: | 13533-631-02 |
| Package Description: | 1 SYRINGE in 1 CARTON (13533-631-02) > 1500 [iU] in 1 SYRINGE (13533-631-20) |
NDC Information of HyperRHO S/D Full Dose
| NDC Code | 13533-631-02 |
| Proprietary Name | HyperRHO S/D Full Dose |
| Package Description | 1 SYRINGE in 1 CARTON (13533-631-02) > 1500 [iU] in 1 SYRINGE (13533-631-20) |
| Product NDC | 13533-631 |
| Product Type Name | PLASMA DERIVATIVE |
| Non Proprietary Name | Rho(D) Immune Globulin (Human) |
| Dosage Form Name | SOLUTION |
| Route Name | INTRAMUSCULAR |
| Start Marketing Date | 19960814 |
| Marketing Category Name | BLA |
| Labeler Name | Grifols Therapeutics Inc. |
| Substance Name | HUMAN RHO(D) IMMUNE GLOBULIN |
| Strength Number | 1500 |
| Strength Unit | [iU]/[iU] |
| Pharmaceutical Classes | Human Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Endogenous Antigen Neutralization [MoA],Immunoglobulins [Chemical/Ingredient] |
